AskTheDate.com
Back to calendar

Cullinan Therapeutics, Inc. (CGEM) Earnings

CGEM reports earnings on Thursday, August 6, 2026

earnings report
August 6, 2026
Q2 2026
Est. EPS: $-0.85
Actual EPS: $-0.81
EPS surprise: -1.34%
Company overview
Market Cap$1.3B
PriceUSD 19.51
EPS (TTM)-3.39
52-week high19.94
52-week low5.68
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees109